thiazoles has been researched along with fondaparinux in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (80.00) | 24.3611 |
| 2020's | 3 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kapiotis, S; Kunitada, S; Mendell, J; Ogata, K; Samama, MM; Wolzt, M | 1 |
| Guinet, C; Kunitada, S; Le Flem, L; Mendell, J; Samama, MM | 1 |
| Fukuda, T; Honda, Y; Kamisato, C; Morishima, Y; Shibano, T; Tsuji, N | 1 |
| Fukuda, T; Furugohri, T; Honda, Y; Kamisato, C; Kojima, T; Matsushita, T; Morishima, Y; Shibano, T | 1 |
| Ishida, K; Kuroda, R; Kurosaka, M; Matsumoto, T; Sasaki, H; Shibanuma, N; Tateishi, H; Tei, K; Toda, A; Yamashiro, Y | 1 |
| Honda, Y; Kamisato, C; Morishima, Y | 2 |
| Greinacher, A; Selleng, K; Thiele, T | 1 |
| Ito, M; Nakamura, M; Yamada, N | 1 |
| Egawa, T; Izushi, Y; Kiuchi, T; Ookura, Y; Sato, T; Shimada, K; Shiota, N; Takami, Y; Takuma, R; Tetsunaga, T | 1 |
| Muro, M; Yamada, E; Yoshioka, T | 1 |
| Egawa, T; Izushi, Y; Kiuchi, T; Sato, T; Shimada, K; Shiota, N; Takami, Y; Takuma, R; Tetsunaga, T | 1 |
| Ageno, W; Casella, IB; Chee, KH; Desch, M; Donado, E; Goldhaber, SZ; Reilly, PA; Schellong, S; Schulman, S; Singer, DE; Tang, W; Voccia, I | 1 |
| Ebner, M; Lankeit, M | 1 |
| Asti, A; Bottino, R; Di Palma, G; Imbalzano, E; Langella, V; Maresca, G; Pomponi, D; Russo, V; Sassone, C | 1 |
2 review(s) available for thiazoles and fondaparinux
| Article | Year |
|---|---|
Reversal of anticoagulants: an overview of current developments.
Topics: Administration, Oral; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticoagulants; Antithrombins; Benzamides; Clinical Trials as Topic; Dabigatran; Factor Xa; Factor Xa Inhibitors; Fondaparinux; Hemorrhage; Hemostatics; Heparin; Humans; Infusions, Parenteral; Intracranial Hemorrhages; Polysaccharides; Protamines; Pyrazoles; Pyridines; Pyridones; Recombinant Proteins; Rivaroxaban; Thiazoles; Thrombosis; Vitamin K | 2015 |
Current management of venous thromboembolism in Japan: Current epidemiology and advances in anticoagulant therapy.
Topics: Anticoagulants; Fondaparinux; Heparin; Humans; Japan; Polysaccharides; Pulmonary Embolism; Pyridines; Quality of Life; Risk Factors; Thiazoles; Venous Thromboembolism; Venous Thrombosis; Warfarin | 2015 |
1 trial(s) available for thiazoles and fondaparinux
| Article | Year |
|---|---|
Effect of edoxaban on markers of coagulation in venous and shed blood compared with fondaparinux.
Topics: Antithrombin III; beta-Thromboglobulin; Biomarkers; Blood Coagulation; Clinical Protocols; Clinical Trials, Phase III as Topic; Drug Dosage Calculations; Factor Xa Inhibitors; Fondaparinux; Humans; Male; Peptide Fragments; Peptide Hydrolases; Platelet Activation; Polysaccharides; Prothrombin; Pyridines; Thiazoles | 2011 |
12 other study(ies) available for thiazoles and fondaparinux
| Article | Year |
|---|---|
In vitro study of the anticoagulant effects of edoxaban and its effect on thrombin generation in comparison to fondaparinux.
Topics: Anticoagulants; Blood Coagulation; Blood Platelets; Cells, Cultured; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Fondaparinux; Humans; In Vitro Techniques; Polysaccharides; Pyridines; Thiazoles; Thrombin | 2012 |
Comparison of antithrombotic efficacy between edoxaban, a direct factor Xa inhibitor, and fondaparinux, an indirect factor Xa inhibitor under low and high shear rates.
Topics: Animals; Anticoagulants; Antithrombins; Blood Flow Velocity; Carotid Arteries; Disease Models, Animal; Factor Xa Inhibitors; Fondaparinux; Humans; Male; Polysaccharides; Pyridines; Rats; Rats, Wistar; Thiazoles; Thrombosis; Vena Cava, Inferior | 2011 |
Impact of antithrombin deficiency on efficacy of edoxaban and antithrombin-dependent anticoagulants, fondaparinux, enoxaparin, and heparin.
Topics: Animals; Anticoagulants; Antithrombin III; Blood Coagulation Tests; Enoxaparin; Factor Xa Inhibitors; Female; Fondaparinux; Gene Deletion; Hemostasis; Male; Mice; Mice, Inbred C57BL; Polysaccharides; Pyridines; Thiazoles; Venous Thrombosis | 2013 |
Retrospective comparison of three thromboprophylaxis agents, edoxaban, fondaparinux, and enoxaparin, for preventing venous thromboembolism in total knee arthroplasty.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Knee; Dose-Response Relationship, Drug; Enoxaparin; Female; Fondaparinux; Humans; Incidence; Knee Joint; Male; Osteoarthritis, Knee; Polysaccharides; Pyridines; Retrospective Studies; Thiazoles; Treatment Outcome; Venous Thromboembolism; Venous Thrombosis | 2014 |
Treatment of venous thrombosis with an oral direct factor Xa inhibitor edoxaban by single and multiple administrations in rats.
Topics: Administration, Oral; Animals; Anticoagulants; Antithrombin III; Disease Models, Animal; Drug Administration Schedule; Enoxaparin; Factor Xa Inhibitors; Fondaparinux; Male; Peptide Hydrolases; Polysaccharides; Pyridines; Rats; Rats, Wistar; Thiazoles; Venous Thrombosis | 2014 |
Edoxaban, a direct factor Xa inhibitor, suppresses tissue-factor induced human platelet aggregation and clot-bound factor Xa in vitro: Comparison with an antithrombin-dependent factor Xa inhibitor, fondaparinux.
Topics: Antithrombins; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Factor Xa; Factor Xa Inhibitors; Female; Fondaparinux; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Polysaccharides; Pyridines; Thiazoles; Thromboplastin | 2016 |
Clinical Assessment of Postoperative Anemia Associated with Edoxaban in Patients Undergoing Total Knee Arthroplasty Compared to Fondaparinux.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anemia; Arthroplasty, Replacement, Knee; Factor Xa Inhibitors; Female; Fondaparinux; Humans; Injections, Subcutaneous; International Normalized Ratio; Male; Partial Thromboplastin Time; Polysaccharides; Postoperative Complications; Prothrombin Time; Pyridines; Thiazoles; Thrombosis | 2016 |
[Venous Thromboembolism during the Cisplatin-based Adjuvant Chemotherapy;Report of a Case].
Topics: Anticoagulants; Chemotherapy, Adjuvant; Cisplatin; Drug Substitution; Drug Therapy, Combination; Echocardiography; Female; Fibrinolytic Agents; Fondaparinux; Humans; Lung Neoplasms; Middle Aged; Polysaccharides; Pyridines; Thiazoles; Thrombolytic Therapy; Tomography, X-Ray Computed; Treatment Outcome; Urokinase-Type Plasminogen Activator; Venous Thromboembolism | 2016 |
The clinical impact of edoxaban for the patients with postoperative anemia after total hip arthroplasty.
Topics: Aged; Aged, 80 and over; Anemia; Anticoagulants; Arthroplasty, Replacement, Hip; Blood Coagulation Tests; Chemoprevention; Factor Xa Inhibitors; Female; Fondaparinux; Humans; Male; Middle Aged; Predictive Value of Tests; Pyridines; Retrospective Studies; Thiazoles; Venous Thromboembolism | 2018 |
Profile of Patients Diagnosed With Acute Venous Thromboembolism in Routine Clinical Practice: The RE-COVERY DVT/PE™ Study.
Topics: Administration, Oral; Adult; Age Distribution; Aged; Anticoagulants; Asia; Comorbidity; Cross-Sectional Studies; Dabigatran; Diabetes Mellitus; Europe; Factor Xa Inhibitors; Female; Fondaparinux; Heparin; Humans; Hypertension; Latin America; Male; Middle Aged; Middle East; Neoplasms; Postoperative Complications; Practice Patterns, Physicians'; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Venous Thromboembolism; Venous Thrombosis; Wounds and Injuries | 2020 |
[Antithrombotic Treatment of Pulmonary Embolism].
Topics: Acute Disease; Dalteparin; Dose-Response Relationship, Drug; Drug Administration Schedule; Fibrinolytic Agents; Fondaparinux; Guideline Adherence; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Humans; Long-Term Care; Neoplasms; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Recurrence; Risk Assessment; Risk Factors; Rivaroxaban; Thiazoles | 2020 |
Edoxaban for the treatment of pulmonary embolism in hospitalized COVID-19 patients.
Topics: Adult; Aged; COVID-19; Factor Xa Inhibitors; Female; Fondaparinux; Humans; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Pulmonary Embolism; Pyridines; Respiratory Distress Syndrome; Retrospective Studies; SARS-CoV-2; Thiazoles | 2021 |